Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Karen, S King"'
Autor:
Linda P. Briley, Lini Pandite, Dana Fraser, Karen S. King, Xiaojing Wang, Sandy Stinnett, Colin F Spraggs, Alan P. Graves, Andreas du Bois, Hiroomi Tada, Ionel Mitrica, Matthew R. Nelson, Neil Kaplowitz, Zhengyu Xue, Thomas Powles, Liling Warren, Christopher L. Carpenter, Toby Johnson, Chun-Fang Xu
Publikováno v:
Clin Cancer Res
Purpose: Pazopanib is an effective treatment for advanced renal cell carcinoma and soft-tissue sarcoma. Transaminase elevations have been commonly observed in pazopanib-treated patients. We conducted pharmacogenetic analyses to explore mechanistic in
Autor:
F. Forget, Michael Friedlander, Sandy Stinnett, Claudio Zamagni, Karen S. King, Martin Imhof, Sang Yoon Park, Dearbhaile E. O’Donnell, Chun Fang Xu, Dominique Berton-Rigaud, Philipp Harter, Toby Johnson, John K. Chan, Nicoletta Colombo, Andreas du Bois, Florian Heitz, Mansoor Raza Mirza, Catherine Barrett, Muneaki Shimada, Thomas J. Herzog, Josep M. del Campo, Minesh Jobanputra
Publikováno v:
Gynecologic oncology. 140(3)
Objective AGO-OVAR 16 demonstrated that pazopanib maintenance therapy significantly increased progression-free survival (PFS) in patients with ovarian cancer whose disease had not progressed after first-line therapy. In a sub-study, we evaluated the
Autor:
Chun-Fang Xu, N. Bing, Vincent Mooser, Karen S. King, Lini Pandite, H. A. Ball, Leigh Ragone, Colin F. Spraggs, Zhengyu G. Xue, Thomas E. Hutson, Dilip Rajagopalan, Paul de Souza, Cora N. Sternberg, Lon R. Cardon, John C. Whittaker, Lauren McCann
Publikováno v:
Journal of Clinical Oncology. 29:2557-2564
Purpose Pazopanib, an oral angiogenesis inhibitor, is approved for the treatment of advanced renal cell carcinoma (RCC). Response to pazopanib monotherapy varies between patients, and no validated biomarkers predictive of treatment outcome have been
Autor:
Zhengyu Xue, N. Bing, P. de Souza, Colin F. Spraggs, Vincent Mooser, Lini Pandite, V. L. Goodman, Chun-Fang Xu, Lauren McCann, Karen S. King
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 23(9)